Utility of Restrata With Split-thickness Skin Graft to Reconstruct the Forearm Donor Site
NCT ID: NCT04880603
Last Updated: 2022-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
5 participants
INTERVENTIONAL
2021-04-05
2022-04-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Radial Forearm Versus the Ulnar Forearm Free Flap
NCT03579277
FCR or APL in LRTI - A Single Surgeon Randomized Controlled Trial
NCT02540057
Hand Transplantation for the Reconstruction of Below the Elbow Amputations
NCT00778856
Hand Transplantation
NCT02476838
Clinical Analysis of a Novel Flexor Tendon Repair Technique
NCT07068880
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A - Standard of Care
Standard of Care Skin Graft
Standard of Care Skin Graft
B - Restrata Graft
Restrata Graft
Restrata will be meshed in a 1:2 fashion to allow for egress of serous fluid and minimize risk of fluid collection. Restrata will be applied to the entire wound bed not amenable to primary closure and will be underlaid beneath the surrounding skin edges. A split-thickness skin graft is harvested from patient's thigh at 15:1000 inches and placed on top of the Restrata to cover the entire wound bed. The graft is sutured in place using suture choice of surgeon's preference.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Restrata Graft
Restrata will be meshed in a 1:2 fashion to allow for egress of serous fluid and minimize risk of fluid collection. Restrata will be applied to the entire wound bed not amenable to primary closure and will be underlaid beneath the surrounding skin edges. A split-thickness skin graft is harvested from patient's thigh at 15:1000 inches and placed on top of the Restrata to cover the entire wound bed. The graft is sutured in place using suture choice of surgeon's preference.
Standard of Care Skin Graft
Standard of Care Skin Graft
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Photo documentation of wound bed at two weeks and four weeks must be obtainable either by physician or patient.
Exclusion Criteria
* Diabetes mellitus with most recent Hemoglobin A1c ≥10.0 within 30 days prior to surgery.
* Morbid obesity (BMI \>40).
* Inability to maintain wrist immobilization for full planned period.
* Severe malnutrition (prealbumin levels \<10 mg per dL within 30 days prior to surgery OR BMI \<15 (very severely underweight).
* Other conditions felt to significantly impair wound healing per surgeon discretion
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acera Surgical, Inc.
INDUSTRY
Nebraska Methodist Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Lindau, MD
Role: PRINCIPAL_INVESTIGATOR
Nebraska Methodist Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nebraska Methodist Hospital
Omaha, Nebraska, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Restrata
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.